Enovis (ENOV) Net Income towards Common Stockholders (QoQ) (2010 - 2026)
Enovis (ENOV) Net Income towards Common Stockholders (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Enovis | 1.51 Bn | 1.50 Bn | 359.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 97.64% |
| Dec 31, 2025 | -4,027.50% |
| Oct 3, 2025 | 56.99% |
| Jul 4, 2025 | 25.60% |
| Apr 4, 2025 | -129.34% |
| Dec 31, 2024 | -81.01% |
| Sep 27, 2024 | 3,398.53% |
| Dec 31, 2023 | -99.93% |
| Sep 29, 2023 | 246.28% |
| Jun 30, 2023 | 1,637.50% |
| Mar 31, 2023 | -101.92% |
| Dec 31, 2022 | 3,186.72% |
| Sep 30, 2022 | 98.79% |
| Jul 1, 2022 | -389.79% |
| Apr 1, 2022 | 6.31% |
| Dec 31, 2021 | -45.17% |
| Oct 1, 2021 | -9.75% |
| Jul 2, 2021 | 50.16% |
| Apr 2, 2021 | 357.58% |
| Dec 31, 2020 | -155.24% |